Successful, highly experienced drug discovery and preclinical development leader in metabolic diseases (type 2 diabetes, obesity), cardiovascular disease (hypertension, endothelial dysfunction) and central nervous system disease (diabetic naturopathic pain and Alzheimer’s disease). International exposure in running both large and small drug discovery (biology and chemistry) and preclinical development programs up to phase IIa. Experience in large medium, biotech and consulting companies operating within different cultures and languages. Experienced in interfacing with all clinical phases - IIa, III and IV and driving translational science to improve drug efficacy and targeting. Extensive contacts and collaborations with experts in the above therapeutic areas and the recipient of numerous major North American and European government grants for the industry. Currently looking for new opportunities in Pharma/Biotech, private equity or consulting.